checkAd
    Startseite > Aktien > Nymox Pharmaceutical > Nachrichten
    Nymox Pharmaceutical Aktie
    0,2169
     
    USD
    -1,37 %
    -0,0030 USD
    Letzter Kurs 18:14:55 Nasdaq OTC
    ISIN: BSP733981026 · WKN: A144CA · SYM: NYMXF · Bahamas

    Neueste Nachrichten

    Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
    27.03.24 · globenewswire · Nymox Pharmaceutical
    Nymox December 27 Message to Shareholders
    27.12.23 · globenewswire · Nymox Pharmaceutical
    Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
    30.11.23 · globenewswire · Nymox Pharmaceutical
    $250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
    21.11.23 · globenewswire · Nymox Pharmaceutical
    Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
    09.11.23 · globenewswire · Nymox Pharmaceutical
    NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
    03.11.23 · globenewswire · Nymox Pharmaceutical
    NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
    03.11.23 · globenewswire · Nymox Pharmaceutical
    IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
    02.11.23 · globenewswire · Nymox Pharmaceutical
    IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
    31.10.23 · globenewswire · Nymox Pharmaceutical
    Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
    27.10.23 · globenewswire · Nymox Pharmaceutical
    Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
    26.10.23 · globenewswire · Nymox Pharmaceutical
    Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
    25.09.23 · globenewswire · Nymox Pharmaceutical